News | News By Subject | News by Disease News By Date | Search News

Alzheimer's Disease News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Astellas Pharma Inc., CoMentis, Inc. Terminate Alzheimer's Agreement     10/17/2014
Actavis Will Keep Selling Alzheimer's Drug In U.S. For 60 Days     9/26/2014
Google Inc.-Backed Calico Announces Plan To Combat ALS, Parkinson's     9/16/2014
AVANIR Pharmaceuticals Rockets As Lead Drug Succeeds In Reducing Alzheimer's Related Agitation; Stock Up 63.20% At 10:19AM ET On Monday     9/16/2014
Roche Alzheimer's Drug Crenezumab Fails Main Goals In Phase 2 Study     7/17/2014
Targacept, Inc. Stops Alzheimer's Drug Trial After It Fails Phase 2b Trial     7/16/2014
Novartis AG To Test Alzheimer's Drugs In Patients Without Symptoms     7/15/2014
German Database Study Hints Takeda Pharmaceutical Co. Ltd.'s Diabetes Drug Cuts Alzheimer's Risk     7/14/2014
Bionomics Limited Clinches Alzheimer's Research And Funding Deal With Merck & Co., Inc. Worth Up To $526 Million     6/24/2014
Breakthrough: AFFiRiS AG Claims A First In Alzheimer's Disease Therapy     6/6/2014
Neurotez, Inc., GCA Therapeutics Strike $102.5 Million+ Alzheimer's Pact     5/21/2014
AstraZeneca PLC Seeks Partner For Potential $5 Billion Alzheimer's Blockbuster     5/8/2014
PRANA Biotechnology Tanks As Lead Drug Fails Alzheimer's Study     4/1/2014
Anavex Life Sciences Corp. Successfully Closes $10 Million Financing To Initiate Phase 1b/2a Alzheimer's Clinical Trial     3/19/2014
Biogen Idec, Inc. (Massachusetts) Buys Rights To Eisai Company, Ltd. Alzheimer's Drugs, Amount Undisclosed     3/5/2014

Featured Stories
Scientists Inch Closer To Alzheimer's Origins, Massachusetts General Hospital Study     10/16/2014
Memory Loss From Alzheimer's Reversed, University of California, Los Angeles (UCLA) Study     10/9/2014
Jealousy, Moody Women, And Alzheimer's Risk, University of Gothenburg Study     10/6/2014
Neural Compensation Found In People With Alzheimer’s-Related Protein, University of California, Berkeley (CAL) Study     9/15/2014
Popular Anxiety Drugs Linked To Alzheimer's, University of Bordeaux Study     9/12/2014
Marijuana Compound Could Stop Or Slow Down Alzheimer’s, University of South Florida Study     9/2/2014
Eating Baked Or Broiled Fish Weekly Boosts Brain Health, University of Pittsburgh Study Says     8/5/2014
Fish Oil Supplements May Improve Memory, Slow Cognitive Decline, Rhode Island Hospital Study     7/17/2014
Taking B Vitamins Won’t Prevent Alzheimer's Disease, University of Oxford Study     7/17/2014
10 Proteins In The Blood That Can Predict The Early Alzheimer's Identified, King's College London Reveals     7/10/2014
Alzheimer's Disease To Brain Hyperactivity, Tel Aviv University Study     7/2/2014
Drug Could Stop Alzheimer's By Targeting Clotting Protein, Rockefeller University Study     6/30/2014
Cocoa Extract May Help Treat And Prevent Alzheimer's, Mount Sinai Hospital Study     6/26/2014
Feeding The Brain's Curiosity Holds Off Alzheimer's, Mayo Clinic Study     6/25/2014
Could Brain's "Internal Marijuana" Prevent Alzheimer's? Stanford University Study     6/20/2014

More News
UBM Medica US Release: Neurology Times Features Coverage Of Parkinson And Alzheimer Disease     10/17/2014
Amarantus BioSciences, Inc. Announces Positive LP-002 Data For Alzheimer's Blood Diagnostic Lympro Test®     10/9/2014
AVANIR Pharmaceuticals (AVNR) Announces Data Presentations At The American Neurological Association's (ANA) 2014 Annual Meeting Including Results From The Phase 2 Trial For Treatment Of Agitation In Patients With Alzheimer's Disease     10/8/2014
The ALS Association Announces Initial Commitment Of $21.7 Million From Ice Bucket Challenge Donations To Expedite Search For Treatments And A Cure For ALS     10/2/2014
FDA Approves NeuroGenetic Pharmaceuticals, Inc. Application To Begin Clinical Trials For Its NGP 555 Compound To Treat And Prevent Alzheimer’s Disease     9/29/2014
GliaCure Enters First-In-Human Clinical Trial In Alzheimer's Disease     9/26/2014
Promising Alzheimer's Treatment Being Tested By NeuroEM Therapeutics And A Leading U.S. Research University     9/25/2014
TauRx Therapeutics Achieves Enrollment Target For Second Phase 3 Clinical Trial Of LMTX™ In Alzheimer's Disease     9/22/2014
Neuraltus Pharmaceuticals, Inc.' ALS Treatment Candidate, NP001, Highlighted At ALS Research Group Summit     9/17/2014
Amarantus BioSciences, Inc. Completes Enrollment Of 72 Patient LP-002 Clinical Study For Alzheimer's Blood Diagnostic Lympro Test®     9/12/2014
Nanosomix Announces New Blood Test For Use By Alzheimer’s Disease Researchers     9/10/2014
Positive Phase 1a Outcome For Memogain®     9/9/2014
Amarillo Biosciences (AMAR) Initiates CLIA Development Of Alzheimer's Blood Diagnostic Lympro Test® At ICON Central Laboratories     9/2/2014
The ALS Association Is Grateful For Outpouring Of Support: Ice Bucket Donations Reach $88.5 Million     8/27/2014
Anavex Life Sciences Corp. (AVXL.OB) Selects The Alfred Hospital In Melbourne, Australia As Lead Site For Phase 2a Alzheimer's Clinical Trial     8/26/2014